The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Socioeconomic Inequalities in Lung Cancer Treatment: Systematic Review and Meta-Analysis
Open accessAbstract
BACKGROUND: Intervention-generated inequalities are unintended variations in outcome that result from the organisation and delivery of health interventions. Socioeconomic inequalities in treatment may occur for some common cancers. Although the incidence and outcome of lung cancer varies with socioeconomic position (SEP), it is not known whether socioeconomic inequalities in treatment occur and how these might affect mortality. We conducted a systematic review and meta-analysis of existing research on socioeconomic inequalities in receipt of treatment for lung cancer. METHODS AND FINDINGS: MEDLINE, EMBASE, and Scopus were searched up to September 2012 for cohort studies of participants with a primary diagnosis of lung cancer (ICD10 C33 or C34), where the outcome was receipt of treatment (rates or odds of receiving treatment) and where the outcome was reported by a measure of SEP. Forty-six papers met the inclusion criteria, and 23 of these papers were included in meta-analysis. Socioeconomic inequalities in receipt of lung cancer treatment were observed. Lower SEP was associated with a reduced likelihood of receiving any treatment (odds ratio [OR] = 0.79 [95% CI 0.73 to 0.86], p<0.001), surgery (OR = 0.68 [CI 0.63 to 0.75], p<0.001) and chemotherapy (OR = 0.82 [95% CI 0.72 to 0.93], p = 0.003), but not radiotherapy (OR = 0.99 [95% CI 0.86 to 1.14], p = 0.89), for lung cancer. The association remained when stage was taken into account for receipt of surgery, and was found in both universal and non-universal health care systems. CONCLUSIONS: Patients with lung cancer living in more socioeconomically deprived circumstances are less likely to receive any type of treatment, surgery, and chemotherapy. These inequalities cannot be accounted for by socioeconomic differences in stage at presentation or by differences in health care system. Further investigation is required to determine the patient, tumour, clinician, and system factors that may contribute to socioeconomic inequalities in receipt of lung cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The results show that disparities in race,128–131 sex,132 socioeconomic status,132–135 level of education,136 residence,128,136 and insurance status,137–139 among other factors, continue to be associated with outcomes such as mortality,128,140 incidence,137,140 stage at diagnosis, and timely receipt of recommended treatment129,131 for patients with NSCLC.”
From Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update (2015) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. H. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Uncertainty in heterogeneity estimates in meta-analyses
Ioannidis, J. P. A., Patsopoulos, N. A., & Evangelou, E. (2007) · BMJ · doi:10.1136/bmj.39343.408449.80 · Cited by 1,254
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–221 of 221
Wallar, L. E., Prophetis, E. D., & Rosella, L. C. (2020) · Figshare · doi:10.6084/m9.figshare.12246482
Bourgeois, A., Horrill, T. C., Mollison, A., Stringer, E., Lambert, L. K., & Stajduhar, K. (2024) · Figshare · doi:10.6084/m9.figshare.26726669
Wallar, L. E., Prophetis, E. D., & Rosella, L. C. (2020) · Figshare · doi:10.6084/m9.figshare.12246485
Bourgeois, A., Horrill, T. C., Mollison, A., Stringer, E., Lambert, L. K., & Stajduhar, K. (2024) · Figshare · doi:10.6084/m9.figshare.26726666
Lückmann, S. L., Hoebel, J., Roick, J., Markert, J., Spallek, J., Knesebeck, O. V. D., & Richter, M. (2021) · Figshare · doi:10.6084/m9.figshare.13889004
Lückmann, S. L., Hoebel, J., Roick, J., Markert, J., Spallek, J., Knesebeck, O. V. D., & Richter, M. (2021) · Figshare · doi:10.6084/m9.figshare.13889007
Wakefield, D., Dehpour, T., Bambra, C., Davies, J., Murtagh, F. E., & Koffman, J. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103697
Tesema, G. A., Stirling, R. G., Tessema, Z. T., & Earnest, A. (2026) · BMC Medicine · doi:10.1186/s12916-026-04741-y
Deane, J., Todd, A., Fuller, E. R., Greystoke, A., Masinghe, S., & Sharp, L. (2026) · Lung Cancer · doi:10.1016/j.lungcan.2026.108957
Milewska-Buzun, M., Baranowska, A., Buzun, R., Zarychta, M., & Cybulski, M. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1766006
Davis, L., Horrill, T. C., Griffiths, R., Goldie, C., Hanna, T. P., & Mahar, A. L. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10517-0
Williams, J. E., Jacobson‐Davies, F. E., Jacobs, R. C., & Odell, D. D. (2026) · Journal of Surgical Research · doi:10.1016/j.jss.2026.02.021
Versorgungsungleichheiten in der Onkologie
Schwertel, T., Hansen, T. J., & Ansmann, L. (2026) · Forum · doi:10.1007/s12312-026-01562-1
Will We Need a Novel Heuristic in Resectable Lung Cancer?: A Narrative Review
Gherzi, L., & Alifano, M. (2026) · Current Oncology · doi:10.3390/curroncol33050245
Inequalities in cancer treatment in the UK: A scoping review of epidemiological research. v1Preprint
Perchyk, T., Merrill, L., Gil, N., Abel, G., Morris, E. J., Giles, E., Finn, E., Spencer, K., Brain, K. E., Lemańska, A., et al. (2026) · doi:10.17504/protocols.io.5qpvoezoxl4o/v1
Horrill, T. C., Bourgeois, A., Breik, N., Kleijberg, M., Linton, J., Stirling, M., & Stajduhar, K. (2026) · SSM - Health Systems · doi:10.1016/j.ssmhs.2026.100238
Hill, N. R., Crosbie, A., Szymialis, R., Botros, A., Zhang, Y., & Tapan, Ü. (2026) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552261449764
Dixon, L. K., Cook, A. D., Cook, S., Barber, E., Boudour, J., Conibear, J., West, D., Navani, N., & Cromwell, D. A. (2026) · BMJ Oncology · doi:10.1136/bmjonc-2025-000957
Ist das Soziale auf dem Rückmarsch? Systemische Perspektiven in der psychosozialen Medizin
Maatouk, I., & Reinhardt, F. (2026) · PPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie · doi:10.1055/a-2855-0283
Symptom Experience Following Lung Cancer Surgery
Hopkins, K. G. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Metadata
- Authors
- Forrest, L. F., Adams, J., Wareham, H., Rubin, G., & White, M.
- Affiliations
- Newcastle University (GB)
- Durham University (GB)
- Corresponding author
- Forrest, Lynne F.
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-02-05
- Volume
- 10
- Issue
- 2
- Pages
- e1001376
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3564770
- OpenAlex
- W2147340827
- Cited by
- 220
- References
- 78
- Citations by year
- 2026: 15 · 2025: 20 · 2024: 18 · 2023: 20 · 2022: 13 · 2021: 20 · 2020: 19 · 2019: 20 · 2018: 15 · 2017: 11 · 2016: 12 · 2015: 22 · 2014: 12 · 2013: 3
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Durham Research Online (Durham University) (acceptedVersion, other-oa)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- United Kingdom Clinical Research Collaboration
- Cancer Research UK
- National Institute for Health and Care Research
- British Heart Foundation
- Medical Research Council (MR/K02325X/1)
- Economic and Social Research Council (ES/G007470/1)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Social Sciences › Health › Health disparities and outcomes
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- lung cancer, socioeconomic disparities, health disparities, treatment receipt, socioeconomic position, chemotherapy, radiotherapy, health care access, universal health care, cancer mortality
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Health Services Accessibility, Humans, Infant, Infant, Newborn, Lung Neoplasms, Male, Middle Aged, Outcome and Process Assessment, Health Care, Risk Factors, Socioeconomic Factors, Odds Ratio, Treatment Outcome, Risk Assessment, Healthcare Disparities, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
